Aspirin treatment of mice infected with Trypanosoma cruzi and implications for the pathogenesis of Chagas disease
about
Bioactive lipids in Trypanosoma cruzi infectionCurrent understanding of immunity to Trypanosoma cruzi infection and pathogenesis of Chagas diseaseMetabolic signatures of triatomine vectors of Trypanosoma cruzi unveiled by metabolomicsStructural and functional analysis of a platelet-activating lysophosphatidylcholine of Trypanosoma cruziResveratrol Reverses Functional Chagas Heart Disease in MiceAspirin modulates innate inflammatory response and inhibits the entry of Trypanosoma cruzi in mouse peritoneal macrophages.Role of the aryl hydrocarbon receptor in the immune response profile and development of pathology during Plasmodium berghei Anka infectionSerum proteomic signature of human chagasic patients for the identification of novel potential protein biomarkers of disease.Trypanosoma cruzi infection and endothelin-1 cooperatively activate pathogenic inflammatory pathways in cardiomyocytes.Protective role of acetylsalicylic acid in experimental Trypanosoma cruzi infection: evidence of a 15-epi-lipoxin A₄-mediated effect.Microarray analysis of the mammalian thromboxane receptor-Trypanosoma cruzi interaction.Chagas heart disease: report on recent developments.Cyclooxygenase-2 and Prostaglandin E2 Signaling through Prostaglandin Receptor EP-2 Favor the Development of Myocarditis during Acute Trypanosoma cruzi Infection.The vasculature in chagas disease.Identification of a functional prostanoid-like receptor in the protozoan parasite, Trypanosoma cruzi.The absence of myocardial calcium-independent phospholipase A2γ results in impaired prostaglandin E2 production and decreased survival in mice with acute Trypanosoma cruzi infection.Role of cyclooxygenase-2 in Trypanosoma cruzi survival in the early stages of parasite host-cell interactionInhibition of cyclooxygenase-1 and cyclooxygenase-2 impairs Trypanosoma cruzi entry into cardiac cells and promotes differential modulation of the inflammatory response.Aspirin prevents atrophy of esophageal nitrergic myenteric neurons in a mouse model of chronic Chagas disease.Myenteric neuroprotective role of aspirin in acute and chronic experimental infections with Trypanosoma cruzi.Eicosapentaenoic Acid Modulates Trichomonas vaginalis Activity.Protection of vascular endothelium by aspirin in a murine model of chronic Chagas' disease.Response to Trypanosoma cruzi by Human Blood Cells Enriched with Dentritic Cells Is Controlled by Cyclooxygenase-2 Pathway.Protective effect of aspirin treatment on mouse behavior in the acute phase of experimental infection with Trypanosoma cruzi.Treatment with low doses of aspirin during chronic phase of experimental Chagas' disease increases oesophageal nitrergic neuronal subpopulation in mice.Old Yellow Enzyme from Trypanosoma cruzi Exhibits In Vivo Prostaglandin F2α Synthase Activity and Has a Key Role in Parasite Infection and Drug Susceptibility.Inflammatory and Pro-resolving Lipids in Trypanosomatid Infections: A Key to Understanding Parasite Control
P2860
Q26866224-DE9727F1-6181-478D-8A73-62F1C9EB4E7FQ28391025-B142FEA1-D3B9-4F12-8F82-B6CC174018EFQ28534750-8C338B6D-6CAE-4B00-A1C8-7C29F257F5D2Q28541704-9EC18947-767A-4FCF-A53E-99989EF902D7Q28553008-4420CE5E-EE36-4B29-B056-4254215BF739Q33873763-45BAAD4F-89BA-4280-A7F9-DFA166CF271CQ34058953-3B90952F-6106-4945-8A3C-2001F606F771Q34250328-8D495B12-0C01-4691-BF82-8E20F7223FE8Q34587039-80531167-8745-42A3-801F-FABF3FE4C3D3Q34702419-88D4B560-3888-4F5B-8AEE-5F6ECFBC2B25Q35002378-9F1A65B8-F974-4204-83FF-7401A779AA7CQ35745413-680E75B2-3F16-4BFC-B03F-64DFA2825625Q35754864-61FF7D95-832E-472A-A998-11B4ECD7AAD8Q36569125-355585A2-EF4E-4F41-A394-530DE1BDF036Q36691584-CAB391DE-7557-4028-A67B-05EFAC641DDDQ36970825-1A967530-10B2-4505-B8F6-FF02504FFF2CQ38878504-3C51849A-FA21-4B68-BAFC-8248E86FFA86Q38968695-A55DD6C0-8DE4-4089-B62D-20AC562D180AQ40150193-9F4C0ACC-E460-42D1-87A3-471B133FFF01Q40206121-0B67EA28-C136-4036-A59F-E310C0EA2C64Q41019447-A6A7CD66-8A6B-4BE1-8623-CF523D820952Q44082471-8FAA3776-2E26-4055-81B6-3ABBB5E850DDQ44174009-AADC215C-3C19-450B-938E-4E3FB4F8FA52Q47381302-D1EA1F05-20DE-4F47-8F6F-76D1955BD3DDQ48211134-1A643C7A-9E8C-4BD3-85C6-1DDC278DB355Q54251278-E98D403E-24A7-45BA-BC0B-837ABE234A02Q58728070-B6B4761D-8FCC-4CCC-A13F-8E65E2C88B13
P2860
Aspirin treatment of mice infected with Trypanosoma cruzi and implications for the pathogenesis of Chagas disease
description
2011 nî lūn-bûn
@nan
2011 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Aspirin treatment of mice infe ...... pathogenesis of Chagas disease
@ast
Aspirin treatment of mice infe ...... pathogenesis of Chagas disease
@en
type
label
Aspirin treatment of mice infe ...... pathogenesis of Chagas disease
@ast
Aspirin treatment of mice infe ...... pathogenesis of Chagas disease
@en
prefLabel
Aspirin treatment of mice infe ...... pathogenesis of Chagas disease
@ast
Aspirin treatment of mice infe ...... pathogenesis of Chagas disease
@en
P2093
P2860
P921
P1433
P1476
Aspirin treatment of mice infe ...... pathogenesis of Chagas disease
@en
P2093
Anthony W Ashton
Dazhi Zhao
Eugene J Fine
Fabiana S Machado
Helieh S Oz
Huang Huang
J Elias Collado
Linda A Jelicks
Louis M Weiss
Shankar Mukherjee
P2860
P304
P356
10.1371/JOURNAL.PONE.0016959
P407
P5008
P577
2011-02-15T00:00:00Z